allergan inc (AG4:Berlin)
As of 2:08 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - allergan inc (AG4)
| Name | Board Relationships | Title | Age |
| David E. I. Pyott | 156 Relationships | Chairman, Chief Executive Officer and President | 58 |
| Jeffrey L. Edwards | 2 Relationships | Chief Financial Officer and Executive Vice President of Finance & Business Development | 51 |
| David J. Endicott | 9 Relationships | Corporate Vice President and President of Allergan Medical, Asia Pacific & Latin America | 47 |
| Julian S. Gangolli | No Relationships | Corporate Vice President and President of North America | 54 |
| Douglas S. Ingram J.D., Esq. | No Relationships | Executive Vice President and President of Europe, Africa & Middle East | 49 |
Board Members - allergan inc (AG4)
| Name | Board Relationships | Primary Company | Age |
| David E. I. Pyott | 156 Relationships | Allergan Inc. | 58 |
| Michael R. Gallagher | 8 Relationships | Allergan Inc. | 66 |
| Russell T. Ray | 35 Relationships | HLM Venture Partners | 64 |
| Dawn E. Hudson | 185 Relationships | Grotech Ventures | 55 |
| Trevor M. Jones CBE Ph.D., DSc FKC FPS FRSC Hon FRCP FBPharmcolS | 52 Relationships | Sigma Tau Pharmasource, Inc. | 69 |
Executive Committees* - allergan inc (AG4)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Russell T. Ray | 35 Relationships | 4 Executives |
| Compensation Committee | Dawn E. Hudson | 185 Relationships | 4 Executives |
| Corporate Governance Committee | Michael R. Gallagher | 8 Relationships | 4 Executives |
| Finance Committee | Russell T. Ray | 35 Relationships | 4 Executives |
| Management/Organization Development Committee | Dawn E. Hudson | 185 Relationships | 4 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| AG4:GR | €78.13 EUR | +0.034 |  |
| Company | Last | Change |
| Actavis Inc | $125.50 USD | +1.89 |
| Astellas Pharma Inc | ¥5,830 JPY | -20.00 |
| Regeneron Pharmaceuticals Inc | $266.97 USD | +2.31 |
| Shire PLC | 2,050 GBp | -4.00 |
| Valeant Pharmaceuticals International Inc | C$80.42 CAD | +3.24 |
| View Industry Companies | ||
Industry Analysis
AG4
Industry Average
| Valuation | AG4 | Industry Range |
| Price/Earnings | 26.9x |
|
| Price/Sales | 5.1x |
|
| Price/Book | 5.6x |
|
| Price/Cash Flow | 29.1x |
|
| TEV/Sales | 4.3x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
